Patents by Inventor Matthieu Jean M RAVELINGIEN

Matthieu Jean M RAVELINGIEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000749
    Abstract: The invention relates to pharmaceutical formulations comprising an active pharmaceutical ingredient; and one of or a combination of methacrylic acid copolymer, or a cellulose derivative wherein the active pharmaceutical ingredient is a dengue viral replication inhibitor. Solid dosage forms comprising said pharmaceutical formulations, processes for preparing these and their use in methods of prevention and/or treatment and/or inhibition of viral replication are also described.
    Type: Application
    Filed: November 3, 2021
    Publication date: January 4, 2024
    Inventors: Donghua Zhu, Kristof Leonard Kimpe, Sune Klint Andersen, Matthieu Jean M. Ravelingien, Ivan Henri M. Somers
  • Publication number: 20220056012
    Abstract: The present invention relates to the amorphous form of a MALT1 inhibitor, methods of preparation thereof and pharmaceutical compositions comprising this amorphous form.
    Type: Application
    Filed: August 20, 2021
    Publication date: February 24, 2022
    Inventors: Kristof Leonard KIMPE, Sune Klint ANDERSEN, Matthieu Jean M RAVELINGIEN, Tom Els R HUYBRECHTS